Download PDF
Arthritis und Rheuma 2015; 35(04): 247-250
DOI: 10.1055/s-0037-1618371
Kasuistik
Schattauer GmbH

Granulomatose mit Polyangiitis

P. von Bismarck
1   Klinik für Allgemeine Pädiatrie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel
,
M. Laudien
2   Hals-, Nasen-, Ohrenheilkunde, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel
› Author Affiliations
Further Information

Publication History

Publication Date:
27 December 2017 (online)

    Permissions and Reprints

 

 

  • Literatur

  • 1 Ozen S. et al Paediatric Rheumatology International Trials Organisation (PRINTO). EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 2010; 69 (05) 798-806.
    CrossrefPubMedGoogle Scholar
  • 2 Frosch M, Foell D. Wegener granulomatosis in childhood and adolescence. Eur J Pediatr 2004; 163 (08) 425-434. [Epub 2004 May 27]
    PubMedGoogle Scholar
  • 3 Bohm M. et al Clinical features of childhood granulomatosis with polyangiitis (wegener’s granulomatosis). Pediatr Rheumatol Online J 2014; 12: 18
    CrossrefPubMedGoogle Scholar
  • 4 Cabral DA. et al ARChiVe (A Registry for Childhood Vasculitis: e-entry) Investigators Network. Classification, presentation, and initial treatment of Wegener’s granulomatosis in childhood. Arthritis Rheum 2009; 60 (11) 3413-3424.
    CrossrefPubMedGoogle Scholar
  • 5 Eustaquio ME. et al Multilevel airway involvement in children with Wegener’s granulomatosis: clinical course and the utility of a multidisciplinary approach. Arch Otolaryngol Head Neck Surg 2011; 137 (05) 480-485.
    CrossrefPubMedGoogle Scholar
  • 6 Jordan NP, Verma H, Siddiqui A. et al Morbidity and mortality associated with subglottic laryngotracheal stenosis in granulomatosis with polyangiitis (Wegener’s granulomatosis): a single-centre experience in the United Kingdom. J Laryngol Otol 2014; 128 (09) 831-837.
    CrossrefPubMedGoogle Scholar
  • 7 Guardiani E. et al. Multilevel airway stenosis in patients with granulomatosis with polyangiitis (Wegener’s). Am J Otolaryngol 2014 Dec 31
    Google Scholar
  • 8 Mukhtyar C. et al European Vasculitis Study Group. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 2009; 68 (03) 310-317.
    CrossrefPubMedGoogle Scholar
  • 9 Jones RB. et al. for the European Vasculitis Society (EUVAS). Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial. Ann Rheum Dis 2015 Mar 4
    PubMedGoogle Scholar
  • 10 Specks U. et al RAVE-ITN Research Group. Efficacy of remission-induction regimens for ANCA-associated vasculitis. N Engl J Med 2013; 369 (05) 417-427.
    CrossrefPubMedGoogle Scholar
  • 11 Guillevin L. et al French Vasculitis Study Group. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med 2014; 371 (19) 1771-1780.
    CrossrefPubMedGoogle Scholar
  • 12 Elgindy EA. et al Gonadatrophin suppression to prevent chemotherapy-induced ovarian damage: a randomized controlled trial. Obstet Gynecol 2013; 121 (01) 78-86.
    CrossrefPubMedGoogle Scholar
  • 13 Stegeman CA. et al Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener’s granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med 1996; 335 (01) 16-20.
    CrossrefPubMedGoogle Scholar
  • 14 Hseu AF. et al Subglottic stenosis: a ten-year review of treatment outcomes. Laryngoscope 2014; 124 (03) 736-741.
    CrossrefPubMedGoogle Scholar
  • 15 Martinez Del Pero M. et al Long-term outcome of airway stenosis in granulomatosis with polyangiitis (Wegener granulomatosis): an observational study. JAMA Otolaryngol Head Neck Surg 2014; 140 (11) 1038-1044.
    CrossrefPubMedGoogle Scholar